Related Experiment Video
Updated: May 20, 2025
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Exploring the Impact of 731 Immunophenotypes on Alopecia Areata Risk: A Mendelian Randomization Analysis With Plasma
Cuimei Wang1, Chong Wu, Hongwei Liang
1The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, China.
Insights
This study reveals a causal link between HLA DR on monocytes and alopecia areata (AA) risk. Specific plasma metabolites partially mediate this relationship, suggesting new avenues for AA research.
Area of Science:
- Immunology
- Genetics
- Metabolomics
Background:
- Alopecia areata (AA) is an autoimmune condition with complex etiology.
- The role of specific immunophenotypes and their causal relationship with AA requires further elucidation.
- Plasma metabolites may act as intermediaries in the development of AA.
Purpose of the Study:
- To determine the causal relationship between immunophenotypes and alopecia areata (AA).
- To investigate the intermediary role of plasma metabolites in the immunophenotype-AA axis.
- To explore potential genetic underpinnings of AA pathogenesis.
Main Methods:
- Bidirectional Mendelian randomization (MR) was employed using genome-wide association study (GWAS) summary statistics.
- 731 immunophenotypes and 1400 plasma metabolites were analyzed for causal associations with AA.
- A 2-step MR strategy assessed metabolite influence on immunophenotypes and subsequent AA risk.
Main Results:
- Elevated genetically predicted HLA DR expression on CD14+ CD16- monocytes was causally associated with increased AA risk (OR = 1.199).
- No robust evidence supported a causal effect of AA on HLA DR expression in these monocytes.
- Glycochenodeoxycholate glucuronide and arachidoylcarnitine (C20) showed mediating effects of 6.5% and 4.7%, respectively.
Conclusions:
- A causal link exists between HLA DR expression on specific monocytes and AA.
- Plasma metabolites, including glycochenodeoxycholate glucuronide and arachidoylcarnitine (C20), partially mediate this relationship.
- Further research is needed to fully understand the mechanisms and identify additional mediators in AA pathogenesis.
Objective:
This study aimed to delineate the causal relationship between immunophenotypes and alopecia areata (AA) and to assess the intermediary role of plasma metabolites.
Methods:
The authors utilized bidirectional Mendelian randomization (MR) to parse the causal associations between 731 immunophenotypes and AA using genome-wide association study (GWAS) summary statistics from 767 cases and 394,105 controls. A 2-step MR strategy was adopted to quantify the influence of 1400 plasma metabolites on AA through their impacts on immunophenotypes.
Results:
The MR findings indicated that an elevated genetically predicted expression of HLA DR on CD14+ CD16- monocytes correlates with an augmented AA risk [Odds Ratio (OR) = 1.199, 95% CI = 1.079-1.332, P = 0.0007]. This association was primarily estimated using the inverse variance weighted (IVW) method. In contrast, the data did not provide robust evidence supporting an influence of genetically predicted AA on the expression of HLA DR in these monocytes (OR = 1.008, 95% CI = 0.989-1.028, P = 0.401). The mediating effect of glycochenodeoxycholate glucuronide on the immunophenotype-AA relationship was quantified at 6.5%, whereas arachidoylcarnitine (C20) mediated 4.7% of the effect.
Conclusion:
The analysis substantiates a causal link between HLA DR expression on CD14+ CD16- monocytes and AA, with partial mediation by arachidoylcarnitine (C20) and glycochenodeoxycholate glucuronide. The principal mechanisms by which HLA DR affects AA are yet to be fully elucidated, necessitating further investigations to uncover additional mediators and risk factors.
More Related Videos
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Related Concept Videos
01:33Pleiotropy
01:35Pedigree Analysis